BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10212298)

  • 1. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of the Lambert-Eaton syndrome antibodies. Downregulation of P/Q-type calcium channels in bovine adrenal chromaffin cells.
    Kim YI; Nam TS; Kim SH; Viglione MP; Kim J
    Ann N Y Acad Sci; 1998 May; 841():677-83. PubMed ID: 9668313
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term changes in the Ca2+-exocytosis relationship during repetitive pulse protocols in bovine adrenal chromaffin cells.
    Engisch KL; Chernevskaya NI; Nowycky MC
    J Neurosci; 1997 Dec; 17(23):9010-25. PubMed ID: 9364048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
    Viglione MP; O'Shaughnessy TJ; Kim YI
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells.
    Magnelli V; Grassi C; Parlatore E; Sher E; Carbone E
    FEBS Lett; 1996 May; 387(1):47-52. PubMed ID: 8654565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
    Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
    Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
    Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lambert-Eaton antibodies promote activity-dependent enhancement of exocytosis in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    Ann N Y Acad Sci; 1999 Apr; 868():213-6. PubMed ID: 10414296
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
    Xu YF; Hewett SJ; Atchison WD
    J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
    Giovannini F; Sher E; Webster R; Boot J; Lang B
    Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
    Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
    Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
    Peers C; Lang B; Newsom-Davis J; Wray DW
    J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels.
    Powell AD; Teschemacher AG; Seward EP
    J Neurosci; 2000 Jan; 20(2):606-16. PubMed ID: 10632590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized L-type calcium channels control exocytosis in cat chromaffin cells.
    López MG; Albillos A; de la Fuente MT; Borges R; Gandía L; Carbone E; García AG; Artalejo AR
    Pflugers Arch; 1994 Jun; 427(3-4):348-54. PubMed ID: 8072856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.